FindTrial
Sign In

HPV test of urine and self-collected vaginal samples for cervical cancer screening

Concordance between urine and self-collected vaginal samples for high risk hpv detection in cervical cancer screening

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/01/049322
Enrollment
2453
Registered
2023-01-31
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

CHITTARANJAN NATIONAL CANCER INSTITUTE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women between 30-60 years willing to participate in the study

Exclusion criteria

Exclusion criteria: 1) Women with previous hysterectomy 2) Previously diagnosed as cervical cancer or precancer lesions. 3) Pregnancy

Design outcomes

Primary

MeasureTime frame
To analyse concordance between first void urine and self collected vaginal sampleTimepoint: 2yr—

Secondary

MeasureTime frame
To determine the acceptability of urine testing for cervical cancer screening. To collect data on the costs associated with implementation of HPV screening by self-sampling and urine analysis with a payer perspective to compare them. Timepoint: 2yr—

Countries

India

Contacts

Public ContactSREEYA BOSE

CHITTARANJAN NATIONAL CANCER INSTITUTE

kranajitmandal@yahoo.co.in9831002078

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 9, 2026